Loading...
XNAS
TRUP
Market cap2.04bUSD
Jul 30, Last price  
47.58USD
1D
-1.53%
1Q
30.57%
Jan 2017
206.57%
IPO
310.17%
Name

Trupanion Inc

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
1.58
EPS
—
Div Yield, %
—
Shrs. gr., 5y
4.00%
Rev. gr., 5y
27.34%
Revenues
1.29b
+15.97%
37,045,00055,530,00083,829,000115,910,000146,963,000188,230,000242,667,000303,956,000383,936,000502,028,000698,991,000905,179,0001,108,605,0001,285,684,000
Net income
-10m
L-78.45%
-3,919,000-6,410,000-8,175,000-21,177,000-17,205,000-6,896,000-1,503,000-927,000-1,809,000-5,840,000-35,530,000-44,672,000-44,693,000-9,633,000
CFO
48m
+159.08%
-112,000-1,543,000-1,023,000-10,801,000-10,425,0005,006,0009,666,00012,680,00016,157,00021,544,0007,458,000-8,000,00018,638,00048,287,000
Earnings
Aug 06, 2025

Profile

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.
URL
https://trupanion.com/
IPO date
Jul 18, 2014
Employees
1,187
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,285,684
15.97%
1,108,605
22.47%
905,179
29.50%
Cost of revenue
1,201,872
1,059,199
937,006
Unusual Expense (Income)
NOPBT
83,812
49,406
(31,827)
NOPBT Margin
6.52%
4.46%
Operating Taxes
(5)
(342)
476
Tax Rate
NOPAT
83,817
49,748
(32,303)
Net income
(9,633)
-78.45%
(44,693)
0.05%
(44,672)
25.73%
Dividends
(6,942)
Dividend yield
0.36%
Proceeds from repurchase of equity
(2,519)
1,119
(7,824)
BB yield
0.12%
-0.09%
0.40%
Debt
Debt current
1,350
1,350
1,103
Long-term debt
127,537
127,580
68,354
Deferred revenue
202,692
Other long-term liabilities
4,476
4,487
(197,724)
Net debt
(178,870)
(161,104)
(160,793)
Cash flow
Cash from operating activities
48,287
18,638
(8,000)
CAPEX
(9,716)
(18,280)
(17,088)
Cash from investing activities
(13,457)
7,639
(67,516)
Cash from financing activities
(3,957)
59,126
60,743
FCF
85,276
36,799
(45,054)
Balance
Cash
307,384
277,168
222,409
Long term investments
373
12,866
7,841
Excess cash
243,473
234,604
184,991
Stockholders' equity
(228,500)
(215,852)
(177,863)
Invested Capital
685,131
652,991
557,585
ROIC
12.53%
8.22%
ROCE
18.28%
11.23%
EV
Common stock shares outstanding
42,159
41,437
40,765
Price
48.20
57.98%
30.51
-35.81%
47.53
-64.00%
Market cap
2,032,053
60.73%
1,264,239
-34.75%
1,937,577
-63.44%
EV
1,853,183
1,103,135
1,776,784
EBITDA
100,278
61,880
(20,906)
EV/EBITDA
18.48
17.83
Interest
14,498
12,077
4,267
Interest/NOPBT
17.30%
24.44%